REabsorbable vs. DUrable Polymer Drug-Eluting Stents in All-Comer PatiEnts: the REDUCE registry-Reference-Cited by-同舟云学术

REabsorbable vs. DUrable Polymer Drug-Eluting Stents in All-Comer PatiEnts: the REDUCE registry

Published:2020-11-20 Issue:4 Volume:32 Page:281-287
ISSN:0954-6928
Container-title:Coronary Artery Disease
language:en
Short-container-title:

Author:

Piccirillo Francesco,Caiazzo Gianluca,Miglionico Marco,Nusca Annunziata,Melfi Rosetta,Gallo Paolo,Ricottini Elisabetta,De Michele Mario,Golino Luca,Manganiello Vincenzo,Fattore Luciano,Mangiacapra Fabio,Di Sciascio Germano

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine,General Medicine

Reference24 articles.

1. Definition and measurement of restenosis after successful coronary angioplasty: implications for clinical trials.;Lespérance;Am Heart J,1993

2. Stent thrombosis.;Holmes;J Am Coll Cardiol,2010

3. Intravascular ultrasound findings in the multicenter, randomized, double-blind RAVEL (RAndomized study with the sirolimus-eluting VElocity balloon-expandable stent in the treatment of patients with de novo native coronary artery Lesions) trial.;Serruys;Circulation,2002

4. Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk.;Joner;J Am Coll Cardiol,2006

5. First-generation versus second-generation drug-eluting stents in current clinical practice: updated evidence from a comprehensive meta-analysis of randomised clinical trials comprising 31 379 patients.;Navarese;Open Heart,2014

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Review and Key Takeaways of the 2021 Percutaneous Coronary Intervention Guidelines;Cardiology in Review;2023-09-20

2. Glycaemic Control in Patients Undergoing Percutaneous Coronary Intervention: What Is the Role for the Novel Antidiabetic Agents? A Comprehensive Review of Basic Science and Clinical Data;International Journal of Molecular Sciences;2022-06-30